6-24806454-T-G
Position:
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 0P and 7B. BP4_StrongBP6_ModerateBP7
The NM_001286445.3(RIPOR2):āc.3063A>Cā(p.Ala1021Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000213 in 1,551,832 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ).
Frequency
Genomes: š 0.00016 ( 0 hom., cov: 33)
Exomes š: 0.00022 ( 0 hom. )
Consequence
RIPOR2
NM_001286445.3 synonymous
NM_001286445.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: -2.30
Genes affected
RIPOR2 (HGNC:13872): (RHO family interacting cell polarization regulator 2) This gene encodes an atypical inhibitor of the small G protein RhoA. Inhibition of RhoA activity by the encoded protein mediates myoblast fusion and polarization of T cells and neutrophils. The encoded protein is a component of hair cell stereocilia that is essential for hearing. A splice site mutation in this gene results in hearing loss in human patients. [provided by RefSeq, Sep 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -7 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.77).
BP6
Variant 6-24806454-T-G is Benign according to our data. Variant chr6-24806454-T-G is described in ClinVar as [Likely_benign]. Clinvar id is 2703036.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr6-24806454-T-G is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=-2.3 with no splicing effect.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RIPOR2 | NM_001286445.3 | c.3063A>C | p.Ala1021Ala | synonymous_variant | 22/22 | ENST00000643898.2 | NP_001273374.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RIPOR2 | ENST00000643898.2 | c.3063A>C | p.Ala1021Ala | synonymous_variant | 22/22 | NM_001286445.3 | ENSP00000494268.2 | |||
ENSG00000282804 | ENST00000562221.1 | c.102A>C | p.Ala34Ala | synonymous_variant | 2/3 | 5 | ENSP00000455145.1 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152248Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
24
AN:
152248
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000203 AC: 32AN: 157650Hom.: 0 AF XY: 0.000216 AC XY: 18AN XY: 83218
GnomAD3 exomes
AF:
AC:
32
AN:
157650
Hom.:
AF XY:
AC XY:
18
AN XY:
83218
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000219 AC: 307AN: 1399466Hom.: 0 Cov.: 31 AF XY: 0.000222 AC XY: 153AN XY: 690248
GnomAD4 exome
AF:
AC:
307
AN:
1399466
Hom.:
Cov.:
31
AF XY:
AC XY:
153
AN XY:
690248
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000158 AC: 24AN: 152366Hom.: 0 Cov.: 33 AF XY: 0.000148 AC XY: 11AN XY: 74508
GnomAD4 genome
AF:
AC:
24
AN:
152366
Hom.:
Cov.:
33
AF XY:
AC XY:
11
AN XY:
74508
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:2
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
RIPOR2-related disorder Benign:1
Likely benign, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | May 17, 2019 | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). - |
not provided Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Sep 21, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at